Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Medibank Private ( (AU:MPL) ) has shared an update.
Medibank Private Limited has notified the ASX of the cessation of 152,254 performance rights (security code MPLAA) as of 31 December 2025, after the conditional rights lapsed because their vesting conditions were not met or became incapable of being satisfied. The lapse of these performance rights effectively reduces the pool of potential future equity issuance under this particular incentive arrangement, which may marginally impact dilution expectations for existing shareholders but does not alter the company’s current issued capital structure.
The most recent analyst rating on (AU:MPL) stock is a Buy with a A$5.50 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is an Australian private health insurance provider listed on the ASX under the code MPL. The company offers a range of health insurance products and related services to individuals and businesses, operating within the broader healthcare and financial services sector.
YTD Price Performance: 0.42%
Average Trading Volume: 5,680,125
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$13.25B
For a thorough assessment of MPL stock, go to TipRanks’ Stock Analysis page.